New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian firm.
The death of children in Gambia had nothing to do with consumption of cough syrup made in India. That has been clarified by the Gambian authorities and DCGI, both: Amit Malviya
The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country have died after taking an India-manufactured cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.
Cough syrup-linked deaths in Uzbekistan: The Health Ministry of Uzbekistan earlier claimed that the 18 children had consumed cough syrup, Doc-1 Max , manufactured by Noida-based Marion Biotech.